Theravance Biopharma, Inc. (TBPH)

16.94 +0.21 (+1.26%) USD  |  NASDAQ  |  May 06, 16:00
16.61 -0.33 (-1.95%) Pre-Market: 20:00
More

Theravance Biopharma Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Integer Holdings Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
QuidelOrtho Corp. Upgrade
Viatris, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade